These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 32495404)

  • 1. Iron Oxide Nanoparticles as T
    Jeon M; Halbert MV; Stephen ZR; Zhang M
    Adv Mater; 2021 Jun; 33(23):e1906539. PubMed ID: 32495404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of micelle-encapsulated extremely small sized iron oxide nanoparticles as a T1 contrast imaging agent: biodistribution and safety profile.
    Suh M; Park JY; Ko GB; Kim JY; Hwang DW; Rees L; Conway GE; Doak SH; Kang H; Lee N; Hyeon T; Lee YS; Lee DS
    J Nanobiotechnology; 2024 Jul; 22(1):419. PubMed ID: 39014410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis Of PEG-Coated, Ultrasmall, Manganese-Doped Iron Oxide Nanoparticles With High Relaxivity For T
    Xiao S; Yu X; Zhang L; Zhang Y; Fan W; Sun T; Zhou C; Liu Y; Liu Y; Gong M; Zhang D
    Int J Nanomedicine; 2019; 14():8499-8507. PubMed ID: 31695377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surface impact on nanoparticle-based magnetic resonance imaging contrast agents.
    Zhang W; Liu L; Chen H; Hu K; Delahunty I; Gao S; Xie J
    Theranostics; 2018; 8(9):2521-2548. PubMed ID: 29721097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Facile synthesis of superparamagnetic nickel-doped iron oxide nanoparticles as high-performance
    Lu C; Xu X; Zhang T; Wang Z; Chai Y
    J Mater Chem B; 2022 Mar; 10(10):1623-1633. PubMed ID: 35191907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Performance
    Zhao D; Peng S; Xiao H; Li Q; Chai Y; Sun H; Liu R; Yao L; Ma L
    ACS Appl Bio Mater; 2023 Jun; 6(6):2137-2144. PubMed ID: 37229527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro MRI of biodegradable hybrid (iron oxide/polycaprolactone) magnetic nanoparticles prepared via modified double emulsion evaporation mechanism.
    Ahmed N; Ahmad NM; Fessi H; Elaissari A
    Colloids Surf B Biointerfaces; 2015 Jun; 130():264-71. PubMed ID: 25960142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fe
    Wang S; Li J; Chen L; Zeng J; Gao M
    J Phys Chem Lett; 2024 Aug; 15(34):8861-8866. PubMed ID: 39169277
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of iron oxide nanoparticles as T
    Yang H; Wang H; Wen C; Bai S; Wei P; Xu B; Xu Y; Liang C; Zhang Y; Zhang G; Wen H; Zhang L
    J Nanobiotechnology; 2022 Mar; 20(1):98. PubMed ID: 35236363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analyzing the mechanisms of iron oxide nanoparticles interactions with cells: A road from failure to success in clinical applications.
    Frtús A; Smolková B; Uzhytchak M; Lunova M; Jirsa M; Kubinová Š; Dejneka A; Lunov O
    J Control Release; 2020 Dec; 328():59-77. PubMed ID: 32860925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Programmable Assembly of Iron Oxide Nanoparticles Using DNA Origami.
    Meyer TA; Zhang C; Bao G; Ke Y
    Nano Lett; 2020 Apr; 20(4):2799-2805. PubMed ID: 32208663
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Xu S; Wang J; Wei Y; Zhao H; Tao T; Wang H; Wang Z; Du J; Wang H; Qian J; Ma K; Wang J
    ACS Appl Mater Interfaces; 2020 Dec; 12(51):56701-56711. PubMed ID: 33296181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel Comparative Studies on Mouse Toxicity of Oxide Nanoparticle- and Gadolinium-Based T1 MRI Contrast Agents.
    Chen R; Ling D; Zhao L; Wang S; Liu Y; Bai R; Baik S; Zhao Y; Chen C; Hyeon T
    ACS Nano; 2015 Dec; 9(12):12425-35. PubMed ID: 26567968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted Molecular Iron Oxide Contrast Agents for Imaging Atherosclerotic Plaque.
    Evans RJ; Lavin B; Phinikaridou A; Chooi KY; Mohri Z; Wong E; Boyle JJ; Krams R; Botnar R; Long NJ
    Nanotheranostics; 2020; 4(4):184-194. PubMed ID: 32637296
    [No Abstract]   [Full Text] [Related]  

  • 15. Design considerations for the synthesis of polymer coated iron oxide nanoparticles for stem cell labelling and tracking using MRI.
    Barrow M; Taylor A; Murray P; Rosseinsky MJ; Adams DJ
    Chem Soc Rev; 2015 Oct; 44(19):6733-48. PubMed ID: 26169237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of concern: Gadolinium embedded iron oxide nanoclusters as
    Wang X; Zhou Z; Wang Z; Xue Y; Zeng Y; Gao J; Zhu L; Zhang X; Liu G; Chen X
    Nanoscale; 2024 May; 16(18):9136. PubMed ID: 38661520
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Size and PEG Length-Controlled PEGylated Monocrystalline Superparamagnetic Iron Oxide Nanocomposite for MRI Contrast Agent.
    Deng LH; Jiang H; Lu FL; Wang HW; Pu Y; Wu CQ; Tang HJ; Xu Y; Chen TW; Zhu J; Shen CY; Zhang XM
    Int J Nanomedicine; 2021; 16():201-211. PubMed ID: 33447035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating size-dependent relaxivity of PEGylated-USPIOs to develop gadolinium-free T1 contrast agents for vascular imaging.
    Khandhar AP; Wilson GJ; Kaul MG; Salamon J; Jung C; Krishnan KM
    J Biomed Mater Res A; 2018 Sep; 106(9):2440-2447. PubMed ID: 29664208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biodegradable and biocompatible exceedingly small magnetic iron oxide nanoparticles for T
    Lu X; Zhou H; Liang Z; Feng J; Lu Y; Huang L; Qiu X; Xu Y; Shen Z
    J Nanobiotechnology; 2022 Jul; 20(1):350. PubMed ID: 35908057
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 16.